![MemScan](https://assets-global.website-files.com/63f7de41f77a528517d3bd73/64347a6844d35908e544a1e2_Memscan_fullcolor.png)
MemScan
MemScan is developing a diagnostic method that combines artificial intelligence, fractal analysis, and electroretinography, using a proprietary algorithm, artificial intelligence (AI) and Machine Learning (ML) for the purposes of accurately diagnosing cognitive impairment as early as possible. The technology suite was developed by a clinical team based at the University of Miami Miller School of Medicine and the Bascom Palmer Eye Institute, one of the world’s top eye and vision research centers.
![MemScan](https://assets-global.website-files.com/63f7de41f77a528517d3bd73/64347798250e5f614a54cbbe_memscan-ikove-startup-nursery_web.jpg)
In the News
Ikove and its portfolio of companies are making noise with groundbreaking innovation.
No items found.